Tag: Medicine Man Technologie shares

Industry Focus Areas, Medical

Medicine Man Technologies Closes on Second Phase of Strategic Investment from Dye Capital & Company

July 17, 2019

Via: PR Newswire

DENVER, July 17, 2019 /PRNewswire/ — Medicine Man Technologies, Inc. (OTCQX: MDCL) (“Medicine Man Technologies” or “Company”), today announced that the Company has amended its original securities purchase agreement (SPA) dated June 5, 2019, with strategic partner Dye Capital & […]